Coronavirus vaccine update: Russia to approve second vaccine, real-time review of Pfizer vaccine in Canada

Coronavirus vaccine update: Russia to approve second vaccine, real-time review of Pfizer vaccine in Canada

Russia, which had claimed to have made the first successful coronavirus vaccine, is expected to approve its second vaccine on October 15. In India, the first coronavirus vaccine from Russia, Sputnik V, has suffered a setback. The second coronavirus vaccine has been developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine … Read more

Rich world could be close to normal by late 2021 if vaccine works: Bill Gates

Rich world could be close to normal by late 2021 if vaccine works: Bill Gates

LONDON: Rich countries could be back to close to normal by late 2021 if a COVID-19 vaccine works, is ready soon and distributed properly at scale, billionaire Microsoft founder Bill Gates said on Tuesday. “By late next year you can have things going back pretty close to normal – that’s the best case,” Gates, 64, … Read more

Developing Countries Push to Limit Patent Protections for Covid-19 Vaccines

Developing Countries Push to Limit Patent Protections for Covid-19 Vaccines

A group of developing countries, backed by United Nations agencies and activist groups, is pushing to limit patent protections for Covid-19 vaccines being tested by some of the world’s biggest pharmaceutical companies so that inexpensive copies can be produced for poorer nations. South Africa, Ghana, Senegal, Pakistan and others argue they won’t be able to … Read more

Spread buying MNC stocks over next 12-18 months: Deepak Shenoy

Spread buying MNC stocks over next 12-18 months: Deepak Shenoy

It will take some time for that system to re-energise or to find its feet again. Expect volatility for next one month, says the Founder, Capital Mind. Do you think there would be further weakness in the market both globally as well as locally?There is obviously going to be some pullback. Currently, I do not … Read more

Moderna says more than 40% of participants enrolled for COVID-19 vaccine trial

Moderna says more than 40% of participants enrolled for COVID-19 vaccine trial

Moderna began the study of its vaccine candidate, mRNA-1273, in July and expects to complete enrollment in September. (Reuters photo) Drug developer Moderna Inc on Friday said it has so far enrolled 13,194 participants in the ongoing late-stage 30,000-volunteer U.S. trial testing its COVID-19 vaccine candidate. In a tweet, the company also said that 18% … Read more